ESLAW icon

Estrella Immunopharma, Inc. Warrant
ESLAW

Overview Fund Activity

13 hedge funds and large institutions have $292K invested in Estrella Immunopharma, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$5K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1.64K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
BFM
1
Boothbay Fund Management
New York
$235K 189,899 – –
HCM
2
Highbridge Capital Management
New York
– – – –
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$6.06K 87,500 – –
Walleye Capital
4
Walleye Capital
New York
$4.39K 66,112 – –
WA
5
Whitebox Advisors
Minnesota
$3.02K 45,476 – –
SIA
6
SkyView Investment Advisors
New Jersey
$3K 62,500 – –
Walleye Trading
7
Walleye Trading
New York
$2.47K 37,188 – –
YCM
8
Yakira Capital Management
Connecticut
$2.39K 46,485 – –
CAC
9
Cowen and Company
New York
$1.9K 28,597 – –
CS
10
Clear Street
New York
$1.9K 28,591 – –
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$1.64K 23,753 +1,267 +6%
LCM
12
Landscape Capital Management
New Jersey
$908 13,682 – –
RCM
13
Robinson Capital Management
Michigan
$816 11,805 – –
WAM
14
Wolverine Asset Management
Illinois
$378 5,703 – –
CFGS
15
Concourse Financial Group Securities
Alabama
– – – –
ASM
16
ATW SPAC Management
New York
– – – –
Citigroup
17
Citigroup
New York
– – – –